A report by LifeArc and Genetic Alliance UK is calling for urgent R&D reform to improve care, access, and treatment.

Large French study reveals intravenous drug users with yeast fungaemia have unique fungal profiles and lower mortality, ...

Discover a study that explores how PARP inhibition with niraparib may offer new therapeutic potential for advanced melanoma ...

See how GLP-1 drugs reduce heart and kidney complications in MGUS and diabetes—explore the clinical evidence. Keep reading!

Thorough screening for latent TB, hepatitis B, and hepatitis C before b/tsDMARD therapy in RA patients improves safety and ...